Eligible Members

In insurance, eligible members refer to individuals who are eligible to participate in an insurance plan or program. Eligibility criteria can vary depending on the type of insurance and the specific plan or program.

For example, in an employer-sponsored health insurance plan, eligible members may include:

• Full-time employees who work a minimum number of hours per week or month

• Part-time employees who work a minimum number of hours per week or month

• Dependents of eligible employees, such as spouses and children

The key features of eligible members in insurance may include:

• Meeting specific criteria to qualify for coverage under a particular insurance plan or program

• Potentially being subject to waiting periods before being eligible to enroll in certain plans or programs

• Qualifying individuals may be required to pay premiums or other costs associated with their coverage

• The eligibility of members may be subject to change based on factors such as employment status or changes in personal circumstances.

Next Up

According to Mployer Insights’ 2026 analysis of 76,000+ employer benefit plans, disability insurance remains a major market differentiator, with only 41% of U.S. employers offering short-term disability (STD) and 38% offering long-term disability (LTD). While 60% salary replacement serves as the national standard across both benefit types, standard plan designs disproportionately expose higher earners due to median benefit caps of $1,602/week for STD and $8,273/month for LTD. Furthermore, alignment between STD benefit durations (median 26 weeks) and LTD elimination periods (68% at 90 days) remains a critical area for plan structure optimization.
Welcome to our latest release. We are excited for you to try the new features.
According to Mployer Insights’ 2026 analysis of 50,000+ employer health plans, prescription drugs account for over 25% of total benefit expenses, with Tier 4 specialty drugs driving the majority of high-cost claims. While Tier 4 copays average $123 with coinsurance requirements in 31% of plans, individual oncology therapies like Darzalex Faspro ($170,800/yr) and Keytruda ($158,200/yr) frequently exceed average individual stop-loss deductibles ($141,938). To mitigate exposure, self-funded employers are increasingly turning to independent, transparent PBM models and biosimilar substitution—which yields up to a 73% net cost reduction per patient.